跳到正文
原文
Endpoints News 生物医药· Kyle LaHucik·· 2026-10-06AI 评分45

Lycia Therapeutics 寻求 IPO,TRexBio 与 Retension 达成融资条款

Lycia seeks IPO for antibody degraders as TRexBio, Retension set terms

AI 导读

Lycia Therapeutics 已提交 IPO 申请,该公司专注于抗体降解剂研发。同时,TRexBio 和 Retension 两家公司已达成融资条款。

正文

Ly­cia Ther­a­peu­tics, a pro­tein degra­da­tion start­up built around sci­ence out of the lab of No­bel lau­re­ate Car­olyn Bertozzi, has filed for an ini­tial pub­lic of­fer­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news